help button home button Am J Pathol ASIP MEMBERSHIP
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Maggio-Price, L.
Right arrow Articles by Iritani, B. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Maggio-Price, L.
Right arrow Articles by Iritani, B. M.
Related Collections
Right arrowRelated Article
(American Journal of Pathology. 2009;174:317-329.)
© 2009 American Society for Investigative Pathology
DOI: 10.2353/ajpath.2009.080485

Bacterial Infection of Smad3/Rag2 Double-Null Mice with Transforming Growth Factor-β Dysregulation as a Model for Studying Inflammation-Associated Colon Cancer

Lillian Maggio-Price*, Piper Treuting*, Helle Bielefeldt-Ohmann{dagger}, Audrey Seamons*, Rolf Drivdahl*, Weiping Zeng{ddagger}, LapHin Lai§, Mark Huycke, Susan Phelps*, Thea Brabb* and Brian M. Iritani*§

From the Department of Comparative Medicine,* University of Washington, Seattle, Washington; the Department of Microbiology, Immunology, and Pathology,{dagger} Colorado State University, Fort Collins, Colorado; Seattle Genetics, Incorporated,{ddagger} Bothell, Washington; the Fred Hutchinson Cancer Research Center,§ Seattle, Washington; and the Medical Service, Departments of Veterans Medical Center and Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma

Alterations in genes encoding transforming growth factor-β-signaling components contribute to colon cancer in humans. Similarly, mice deficient in the transforming growth factor-β signaling molecule, Smad3, develop colon cancer, but only after a bacterial trigger occurs, resulting in chronic inflammation. To determine whether Smad3-null lymphocytes contribute to increased cancer susceptibility, we crossed Smad3-null mice with mice deficient in both B and T lymphocytes (Rag2–/– mice). Helicobacter-infected Smad3/Rag2-double knockout (DKO) mice had more diffuse inflammation and increased incidence of adenocarcinoma compared with Helicobacter-infected Smad3–/– or Rag2–/– mice alone. Adoptive transfer of WT CD4+CD25+ T-regulatory cells provided significant protection of Smad3/Rag2-DKO from bacterial-induced typhlocolitis, dysplasia, and tumor development, whereas Smad3–/– T-regulatory cells provided no protection. Immunohistochemistry, real-time reverse transcriptase-polymerase chain reaction, and Western blot analyses of colonic tissues from Smad3/Rag2-DKO mice 1 week after Helicobacter infection revealed an influx of macrophages, enhanced nuclear factor-{kappa}B activation, increased BclXL/Bcl-2 expression, increased c-Myc expression, accentuated epithelial cell proliferation, and up-regulated IFN-{gamma}, IL-1{alpha}, TNF-{alpha}, IL-1β, and IL-6 transcription levels. These results suggest that the loss of Smad3 increases susceptibility to colon cancer by at least two mechanisms: deficient T-regulatory cell function, which leads to excessive inflammation after a bacterial trigger; and increased expression of proinflammatory cytokines, enhanced nuclear factor-{kappa}B activation, and increased expression of both pro-oncogenic and anti-apoptotic proteins that result in increased cell proliferation/survival of epithelial cells in colonic tissues.



Related Article

This Month in AJP
Angela Colmone
Am. J. Pathol. 2009 174: 1-2. [Full Text] [PDF]






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2009 by the American Society for Investigative Pathology.